When to Order Imaging for Imaging for Pulmonary Embolism, Known Clot: ACR Appropriateness Decoded
When to Order Imaging for Pulmonary Embolism, Known Clot: ACR Appropriateness Decoded
A patient with a history of pulmonary embolism (PE) presents to the emergency department with recurrent shortness of breath and pleuritic chest pain. Their D-dimer is elevated, but that’s expected given their recent history. You suspect a new or residual clot, but what’s the best next step? Ordering another CT Pulmonary Angiogram (CTPA) means more radiation and contrast exposure, but a V/Q scan might not provide the same anatomic detail. This common clinical dilemma is where the American College of Radiology (ACR) Appropriateness Criteria provide essential, evidence-based guidance. This article breaks down the recommendations for imaging patients with a known history of PE to help you choose the right test for the right reason.
What Does ACR Imaging for Pulmonary Embolism, Known Clot Cover?
This ACR guideline focuses specifically on patients with an established diagnosis of pulmonary embolism. It is not intended for the initial workup of a patient with suspected PE for the first time. The recommendations are tailored to two distinct clinical situations:
- Suspected Recurrent or Residual Embolic Disease: This applies to an adult patient with a known history of acute PE who presents with new or worsening symptoms, prompting an evaluation for a new embolic event or persistent clot burden from the initial event.
- Surveillance of Known Chronic Thromboembolic Disease: This scenario covers the routine, planned imaging of an adult patient with diagnosed chronic thromboembolic pulmonary hypertension (CTEPH) or non-hypertensive chronic thromboembolic disease (CTED) to monitor disease progression or stability.
Understanding this scope is critical. If you are evaluating a patient for a first-time PE, you should consult the ACR Appropriateness Criteria for “Suspected Pulmonary Embolism—Initial Evaluation.” This document is strictly for follow-up and surveillance scenarios.
What Imaging Should I Order for Imaging for Pulmonary Embolism, Known Clot? Recommendations by Clinical Scenario
The optimal imaging study depends on whether you are investigating an acute recurrence or performing long-term surveillance. The ACR provides clear, rating-based recommendations for each context.
For an adult with a known history of acute pulmonary embolism and suspected recurrent or residual embolic disease, several modalities are considered Usually Appropriate. CT Pulmonary Angiography (CTPA) with IV contrast is often the workhorse due to its wide availability and excellent anatomic detail, allowing for direct visualization of emboli. A Ventilation/Perfusion (V/Q) scan, including versions with SPECT or SPECT/CT, is also usually appropriate and is a valuable alternative, particularly in patients with contraindications to iodinated contrast (e.g., severe renal impairment or allergy) or in younger patients where radiation dose reduction is a priority. Magnetic Resonance Angiography (MRA) of the chest with IV contrast is another non-ionizing radiation option rated as usually appropriate, though it may be less available and more susceptible to motion artifact.
In this same scenario of suspected recurrence, a resting transthoracic echocardiogram (TTE) is rated as May Be Appropriate. While it cannot directly diagnose a PE, it is crucial for assessing the hemodynamic consequences, such as right ventricular strain, which can significantly impact prognosis and management. Conversely, a standard chest radiograph is Usually Not Appropriate for diagnosing a recurrent PE due to its low sensitivity and specificity, though it may be useful for evaluating for alternative causes of symptoms.
For an adult with known chronic thromboembolic disease undergoing surveillance, the recommendations shift. CTPA with IV contrast remains the sole modality rated as Usually Appropriate. It is the primary tool for monitoring the extent of chronic clot burden and associated vascular changes. Several other tests are rated as May Be Appropriate, often with panel disagreement, reflecting the nuanced, patient-specific nature of surveillance. These include invasive pulmonary arteriography (often in the context of planning for pulmonary thromboendarterectomy), MRA, and V/Q scans. A resting TTE is also rated May Be Appropriate (Disagreement), typically used to monitor for the development or progression of pulmonary hypertension by estimating right ventricular systolic pressure.
ACR Imaging Recommendations Table
| Clinical Scenario | Top Procedure | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Adult. Known history of acute pulmonary embolism. Suspected recurrent or residual embolic disease. Initial imaging. | CTA pulmonary arteries with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Adult. Known chronic thromboembolic disease. Surveillance. | CTA pulmonary arteries with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
Adult vs. Pediatric Imaging for Pulmonary Embolism, Known Clot Imaging: Radiation Dose Tradeoffs
While pulmonary embolism is less common in children, the principles of imaging follow-up and the importance of radiation safety are paramount. The ACR provides distinct pediatric relative radiation level (RRL) estimates, which often reflect higher effective doses for the same procedure compared to adults. For instance, a CTPA is rated as ☢ ☢ ☢ (1-10 mSv) for an adult but ☢ ☢ ☢ ☢ (3-10 mSv [ped]) for a child. This difference underscores the increased radiosensitivity of developing pediatric tissues and the longer lifespan over which potential stochastic effects of radiation could manifest.
This concern reinforces the ALARA (As Low As Reasonably Achievable) principle. For a pediatric patient with a known PE and suspected recurrence, clinicians should strongly consider non-ionizing options like MRA or lower-dose ionizing studies like a V/Q scan (☢ ☢ ☢ 0.3-3 mSv [ped]). The decision between CTPA and V/Q scan in children requires a careful balance between the diagnostic information needed and the long-term risks of cumulative radiation exposure. Communication with a pediatric radiologist is often essential to select the most appropriate and safest imaging modality.
Imaging Protocol Details for Imaging for Pulmonary Embolism, Known Clot
Once you’ve decided on the right study based on the clinical scenario, ensuring it is performed correctly is the next critical step. A suboptimal protocol—whether it’s poor contrast timing on a CTPA or incorrect gating on an MRA—can render a study non-diagnostic and lead to repeat imaging. Our protocol guides provide detailed, practical information on technique, contrast administration, and interpretation principles for the key studies recommended in these guidelines.
Tools to Help You Order the Right Study
Navigating imaging guidelines can be complex, especially when dealing with multiple clinical variables. GigHz offers a suite of free tools designed to support evidence-based clinical decision-making at the point of care.
For scenarios beyond known pulmonary embolism, the ACR Appropriateness Criteria Lookup provides a fast, searchable interface to the full library of ACR guidelines, covering thousands of clinical variants and procedures.
To ensure the selected study is performed to the highest standard, the Imaging Protocol Library offers detailed, step-by-step protocols for hundreds of common and advanced imaging examinations used across radiology departments.
When discussing imaging options with patients, especially those involving radiation, the Radiation Dose Calculator is an invaluable aid. It helps estimate effective radiation dose for various studies and can be used to track cumulative exposure over time, facilitating informed patient consent and shared decision-making.
Why is a chest X-ray ‘Usually Not Appropriate’ for suspected recurrent PE?
A standard chest radiograph has very low sensitivity and specificity for directly diagnosing pulmonary embolism. While it may show secondary signs like a Hampton’s hump or Westermark sign, these are rare and non-specific. Its primary role in this setting is to help identify alternative or co-existing pathologies that could mimic a PE, such as pneumonia, pneumothorax, or pleural effusion, rather than to rule in or rule out a recurrent clot.
When should I choose a V/Q scan over a CTPA for a patient with a known PE history?
A V/Q scan is an excellent alternative to CTPA and is often preferred in specific situations. The most common indications are contraindications to iodinated contrast, such as a history of severe anaphylactic reaction or significant renal insufficiency (acute kidney injury or severe chronic kidney disease). It is also a preferred modality in young patients and pregnant patients due to its substantially lower radiation dose to the chest and breast tissue compared to CTPA.
What is the role of echocardiography in evaluating for recurrent PE?
Echocardiography (TTE) is not used to diagnose a pulmonary embolism directly, as it cannot visualize clots in the pulmonary arteries. Instead, its critical role is to assess the hemodynamic impact of a PE. It evaluates for signs of right heart strain, such as right ventricular dilation, hypokinesis, or elevated right ventricular systolic pressure (pulmonary hypertension). The presence of these findings indicates a more significant, submassive, or massive PE and can heavily influence the decision to pursue more aggressive therapies beyond standard anticoagulation.
Why are there so many ‘May be appropriate (Disagreement)’ ratings for chronic PE surveillance?
The “Disagreement” qualifier indicates that the expert panel did not reach a consensus on the appropriateness of the modality for that specific indication. For chronic PE surveillance, this reflects the lack of high-level, definitive evidence guiding a single best imaging strategy. The optimal approach often varies based on the specific clinical question (e.g., monitoring clot burden vs. monitoring pulmonary pressures), local institutional practice, and individual patient factors. This variability leads to a wider range of “May Be Appropriate” options, empowering clinicians to tailor the surveillance plan to the patient’s needs.
Is invasive pulmonary arteriography ever the right first choice?
No, conventional catheter-based pulmonary arteriography is almost never the first-line diagnostic choice for either acute or chronic PE in the modern era. It has been largely replaced by the high accuracy and non-invasive nature of CTPA. Its use is now reserved for specific, advanced scenarios. It is rated ‘May be appropriate’ in the context of chronic thromboembolic disease surveillance because it is often performed as a prerequisite for, or in conjunction with, therapeutic procedures like pulmonary thromboendarterectomy (PTE) or balloon pulmonary angioplasty (BPA), where it provides essential hemodynamic data and a detailed roadmap of the pulmonary vasculature.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026
